Quality Isn’t Your Brake Pedal. It’s Your Steering Wheel.

“Quality Is Slowing Us Down.” (It Doesn’t Have To.)

I hear this from biotech leadership more often than I’d like. And honestly—I get it.

When you’re burning runway and racing toward IND-enabling studies, your next funding milestone, or your first GMP batch, quality systems can feel like bureaucratic friction: one more approval layer standing between you and the thing that actually matters.

But after 13 years working in FDA GMP- and EPA GLP-regulated environments, I’ve come to believe something that sounds counterintuitive:

The companies that move fastest aren’t skipping quality. They’ve built quality systems that accelerate them.

The difference isn’t whether they have quality. It’s what kind.

---

The Two Types of Quality Systems

Not all quality systems are created equal. There’s a meaningful difference between quality as a compliance tax and quality as an operational advantage.

Bad quality systems are reactive.

They find problems after they’ve already compounded. They generate corrective actions that pile on top of each other. They delay releases while everyone scrambles through investigations that take months. They make “quality” synonymous with “slow,” because every interaction with quality is a crisis.

Good quality systems are proactive.

They catch issues early—when they’re cheap and fast to fix. They streamline decisions by giving people clear authority and clear criteria. They help products get released faster, because the work was done right the first time and the evidence is already there.

The reactive system taxes your speed. The proactive system multiplies it.

---

What “Good Quality” Looks Like in Practice

This isn’t abstract. Here’s where I’ve seen the most time recovered:

1) Design reviews that catch issues before manufacturing—not after

A 30-minute review at the right moment can eliminate a weeks-long investigation down the line. Getting quality eyes on a protocol or process *before execution*—not as a gate, but as a collaborator—is one of the highest-leverage activities a QA team can do.

2) Deviation management measured in days, not months

When a deviation drags on for three months, it’s almost never because the investigation was genuinely complex. It’s usually because the process is unclear, ownership is diffuse, or the CAPA structure requires more justification than the problem warrants. Lean deviation workflows change this.

3) Risk assessments that focus effort where it matters

Treating every risk the same is itself a risk. A well-executed risk assessment lets your team apply deep rigor to the things that could actually derail you—and lighter oversight to the things that won’t. That’s not cutting corners. That’s allocation.

4) Clear decision authority so quality can say “yes” as fast as “no”

One of the most underrated quality system problems is ambiguous approval authority. When no one is sure who can sign off, everything escalates. Defined decision rights—documented, communicated, and trusted—cut approvals from days to hours.

---

The Early-Stage Trap

Early-stage biotechs are especially vulnerable to a false choice: **move fast now, build quality later.**

The reasoning is understandable—you’re pre-revenue, every dollar is precious, and “full GMP” feels like something you build when you have more resources.

But the companies I’ve seen struggle most aren’t the ones who built quality early. They’re the ones who had to retrofit it under pressure—scrambling to reconstruct traceability, re-run studies, or rebuild supplier qualification programs three months before an FDA inspection or a partnership due diligence review.

Quality built at the right scale for your stage is fast and cheap.

Quality retrofitted under pressure is expensive and slow.

---

Speed Comes From Doing Things Once, Correctly

Here’s the reframe that matters most:

A brake pedal is something you press when things go wrong—it stops momentum. A steering wheel is what keeps you moving in the right direction. You don’t drive without one.

When quality is integrated into how your team works—not appended to the end of it—it provides orientation, not obstruction. It answers questions before they become emergencies. It gives you the documentation and the data you need to move confidently, not cautiously.

That’s the quality system worth building.